Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 1, 2000, Pages 65-67

  Fenig, Eyal ^a   Brenner, Baruch ^b   Njuguna, Eliud ^b   Katz, Alan ^b   Schachter, Jacob ^b   Sulkes, Aaron ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Chemotherapy; Merkel cell carcinoma; Oral etoposide; Radiotherapy

Indexed keywords

ETOPOSIDE; GYRASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CASE REPORT; DRUG RESPONSE; HUMAN; MALE; MERKEL CELL TUMOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, MERKEL CELL; CISPLATIN; ETOPOSIDE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID SYNTHESIS INHIBITORS; SKIN NEOPLASMS;

EID: 0034099631     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200002000-00018     Document Type: Article

References (23)

1. Toker C. Trahecular carcinoma of the skin. Arch Dennatol 1972; 105:107-10.
2. De Wolf-Peellers C, Marien K, Meibs J, Desmet V. A cutaneous apudoma or Merkel cell tumor? Cancer 1980;46:1810-6.
3. Sibley RK, Dehner LP, Rusai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin: a clinicopathological and ultrastruclural study of 43 cases. Am J Surg Pathol 1984;9:95-108.
4. Tang C, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978;42:2311-21.
5. Kirkham N, Isaacson P. Merkel cell carcinoma: a report of three cases with neuron-specific enolase activity. Histopathologv 1983; 7:251-9.
6. Gu J, Polak JM, Van Noorden S, et al. Immunostaining of neuron-specific enolase as a diagnostic tool of Merkel cell tumors. Cancer 1983;52:1039-43.
7. Hitchcock CL, Bland KI, Laney RG III, Franzini D, Harris B, Copeland EM III. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988; 207:201-7.
8. Morrison WH, Peters LJ, Silva EG, Wendt CD, Kian Ang K, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990;19:583-91.
9. Raaf JH, Urmacher C, Knapper WK, Shiu MH, Cheng EW. Trabecular (Merkel cell) carcinoma of skin: treatment of primary recurrent and metastatic disease. Cancer 1986;57:178-82.
10. Wynne CJ, Kearsly JH. Merkel cell tumor, a chemosensitive skin cancer. Cancer 1988;62:28-31.
11. Grosh WW, Gioannone L, Hande KR, Johnson DH. Disseminated Merkel cell tumor: treatment with systemic chemotherapy. Am J Clin Oncol 1987;10:227-30.
12. Feun LG, Savaraz N, Legha SS, Silva EG, Benjamin RS, Burgess MA. Chemotherapy for metastatic Merkel cell carcinoma. Review of the MD Anderson Hospital's experience. Cancer 1988;62: 683-5.
13. Davis MP, Miller EM, Rau RC, Johnson OW, Naille RA, Crnkovitch MJ. The use of VP-16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol 1990;16:276-8.
14. Azagury YM, Chevallier B, Atlan D, Graic Y, Dayot JP, Thomine E. VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with Ions term remission. Am J Clin Oncol 1993;16:102-4.
15. Pectasides D, Moutzourides G, Dimitriadis M, Varthahtis J, Athanassiou A. Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol 1995;18:418-20.
16. Faylona EA, Loehrer PJ, Ansari R, Sandler AB, Gonin R, Einhorn LH. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group trial. J Clin Oncol 1995;13:1209-14.
17. Johnson DH, Greco AF, Strupp J, et al. Prolonged administration of oral etoposide in patients with relapsed or refractory small cell lung cancer. A phase II trial. J Clin Oncol 1990;8:1613-7.
18. Haim N, Ben-Shahar M, Epelbaum R. Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, and ifosfamide-containing salvage combination, and intravenous etoposide. Cancer Chemother Pharmacol 1995;36: 352-5.
19. Chantarawiroj P, Tresukosol D, Kudelka AP, Edwards CL, Silva EG, Wharton JT, Kavanagh JJ. Prolonged oral etoposide for refractory advanced uterine leiomyosarcoma. Gynecol Oncol 1995; 58:248-50.
20. Haag ML, Glass LF. Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995;21:669-83.
21. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881-5.
22. Fenig E, Lurie H, Klein H, Sulkes AA. The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol 1993;19: 860-4.
23. Slevin ML, Clark PI, Joel SP, et al. A randomized trial to evaluate lhe effect of schedule on the activity of etoposide in small cell lung cancer. J Clin Oncol 1989;7:1333-40.